Skip to main content

oncostatin M receptor

The OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

Video picks for Genes
Video library

Normal function

The OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

OSM receptor type II interacts with a protein called oncostatin M (OSM). Signaling triggered by OSM was first recognized to block the growth of cancerous cells and appears to play a role in many other body processes, including the development of blood cells, the maturation of cells to become certain cell types, and an immune system response called inflammation. The signaling may also block the self-destruction (apoptosis) of cells.

The IL-31 receptor interacts with a protein called IL-31. Signaling triggered by IL-31 is involved in inflammation and stimulating itching (pruritus), although its role is not completely understood.

Conditions referring to this gene or chromosome

Other names

IL-31 receptor subunit beta

IL-31R subunit beta

IL-31R-beta

IL-31RB

interleukin-31 receptor subunit beta

oncostatin-M specific receptor beta subunit

OSMRB

PLCA1

Patient picks for Genes

Related patient information and medicines

IgA nephropathy

Patient information leaflet

IgA nephropathy

IgA nephropathy is a condition in which a protein causes damage to the kidneys. The medicines used for blood pressure control with IgA nephropathy are angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors or angiotensin receptor blockers (ARBs) - for example, losartan Losartan - an angiotensin receptor blocker. Even if you don't have high.

Coronary artery bypass graft

Patient information leaflet

Coronary artery bypass graft

C oronary artery bypass grafting (CABG) is a type of heart surgery to treat coronary artery disease. The standard surgery requires open heart surgery and stopping of the heart temporarily. Coronary artery bypass grafting, called CABG for short (pronounced 'cabbage'), is a heart operation. It is also called coronary artery bypass surgery. A CABG is.

Dilated cardiomyopathy

Patient information leaflet

Dilated cardiomyopathy

Dilated cardiomyopathy is a condition where the heart muscle becomes stretched and thin. The heart becomes enlarged (dilates) and pumps blood less well. Symptoms vary according to severity and the treatment depends on the type of symptoms and whether any complications develop. Some forms of dilated cardiomyopathy run in families. A normal heart.

Familial hypercholesterolaemia

Patient information leaflet

Familial hypercholesterolaemia

Familial hypercholesterolaemia is inherited high cholesterol. The usual medicine to start with is a statin Statins and other lipid-lowering medicines. ...mmon statin used is called atorvastatinDr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other.

Diabetes and illness

Patient information leaflet

Diabetes and illness

It is very important to know how to cope with illness if you have diabetes or know or care for somebody with diabetes. Further information on managing diabetes during a period of illness is available on the Diabetes UK website (see Further Reading below for the link). On angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors , angiotensin.

Myasthenia gravis

Patient information leaflet

Myasthenia gravis

Myasthenia gravis (MG) is a condition where muscles become easily tired and weak. It is due to a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. What causes myasthenia gravis. Myasthenia gravis is an autoimmune disease. This means that the immune system The immune.

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 Oct 2016 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.